Schedule 13G ownership disclosure

Fate Therapeutics Inc

Security class unavailable · CUSIP: 31189P102

Event date: 2024-01-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,730,700
Percent of class
4.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-24-000657
Form type
SC 13G
Filer
FATE THERAPEUTICS INC
CIK
CIK 1434316
Filed
Jan 25, 2024
Reporting period
Jan 24, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub